Multiple Sclerosis Clinical Trials in New York

Showing 781-800 of 812 trials

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

NCT00059735

The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.

Kidney NeoplasmsCarcinoma, Renal CellAdenocarcinoma, Renal Cell

Eisai Inc.30 participantsStarted May 2002

Sacramento, California, United States • New York, New York, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 1/2< 1 mile

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

NCT00070837

The purpose of the study is to determine the highest dose of MLN2704 that can be given multiple times safely to patients with prostate cancer, and to identify any side effects associated with taking the drug. This study will also evaluate how MLN2704 is taken up, broken down and eliminated by the body.

Prostatic Neoplasms

Millennium Pharmaceuticals, Inc.46 participantsStarted Oct 2003

New York, New York, United States • New York, New York, United States • Durham, North Carolina, United States +1 more locations

COMPLETEDPhase 3< 1 mile

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

NCT00054795

The primary purpose of the study is to determine if patients with brain metastases from non-small cell lung cancer treated with Motexafin Gadolinium and whole brain radiation therapy retain their neurologic function and ability to think for a longer time compared to patients treated with whole brain radiation therapy alone.

Brain NeoplasmsCarcinoma, Non-Small-Cell LungMetastases, Neoplasm

Pharmacyclics LLC.550 participants

Phoenix, Arizona, United States • Fort Smith, Arkansas, United States • Little Rock, Arkansas, United States +89 more locations

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Multiple Sclerosis Trials in Other Cities

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Study Evaluating MST-997 in Advanced Malignant Solid Tumors

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer

Developmental Study on Fatigue in Cancer

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients

The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients

Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

A Study of the Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Other Conditions in New York